Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-01), Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio is -0.01.
Vietnam Medicinal Materials JSC (HSTC:DVM) 1-Year Sharpe Ratio Explanation
The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
Vietnam Medicinal Materials JSC 1-Year Sharpe Ratio Related Terms
HSTC:DVM vs ZTS, UTHR, VTRS: 1-Year Sharpe Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vietnam Medicinal Materials JSC 1-Year Sharpe Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio falls into.
Vietnam Medicinal Materials JSC 1-Year Sharpe Ratio Calculation
The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.
Vietnam Medicinal Materials JSC (HSTC:DVM) has a 1-Year Sharpe Ratio of -0.01 as of Aug. 01, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Vietnam Medicinal Materials JSC and its competitors.
Is Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio too high?
Vietnam Medicinal Materials JSC's current 1-Year Sharpe Ratio is -0.01. Overall, Vietnam Medicinal Materials JSC has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio compare to ZTS and UTHR?
Vietnam Medicinal Materials JSC's 1-Year Sharpe Ratio of -0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Drug Manufacturers company?
A good 1-Year Sharpe Ratio depends on the Drug Manufacturers industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Vietnam Medicinal Materials JSC and its competitors. Vietnam Medicinal Materials JSC's current 1-Year Sharpe Ratio is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vietnam Medicinal Materials JSC stock overvalued right now?
Vietnam Medicinal Materials JSC (HSTC:DVM) has a current 1-Year Sharpe Ratio of -0.01. The current 1-Year Sharpe Ratio is -0.01. Vietnam Medicinal Materials JSC's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Vietnam Medicinal Materials JSC (HSTC:DVM), the current 1-Year Sharpe Ratio is -0.01 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vietnam Medicinal Materials JSC is a company specializing in clean medicinal herbs and is committed to pharmaceuticals and health food products derived from natural medicinal herbs, with product quality as a top priority. Its business areas are the production and wholesale of medicinal herbs. Its activities include manufacturing and trading of pharmaceuticals, cultivation and processing of medicinal herbs, dietary supplements, wholesale and retail of medical products, cosmetics and equipment, and import and export of goods traded by the company. Its products are developed from standardized medicinal herbs under controlled cultivation, harvesting and processing, combining traditional remedies with science under strict quality control.
32GF Score
Get the complete analysis for HSTC:DVM
1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVM has been successfully added to your 
